Roy S K, Behrens R H, Haider R, Akramuzzaman S M, Mahalanabis D, Wahed M A, Tomkins A M
Clinical Sciences Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
J Pediatr Gastroenterol Nutr. 1992 Oct;15(3):289-96. doi: 10.1097/00005176-199210000-00010.
Zinc has been shown to enhance intestinal mucosal repair in patients suffering from acrodermatitis enteropathica; but the impact on mucosal integrity during acute (AD) or persistent (PD) diarrhoea is unknown. One hundred eleven children with AD and 190 with PD aged between 3 and 24 months received, randomly and blind to the investigators, either an elemental zinc supplement of 5 mg/kg body wt/day or placebo in multivitamin syrup for 2 weeks while intestinal permeability and, biochemical and anthropometric markers were serially monitored. The permeability test was administered as an oral dose of 5 g lactulose/l g mannitol in a 20-ml solution followed by a 5-h urine collection. The ratio of the urinary probe sugars was correlated to clinical, biochemical, and microbiological parameters. At presentation, lactulose excretion was increased and mannitol excretion decreased in both AD and PD as compared with age-matched asymptomatic children. The lactulose/mannitol ratio (L/M) was higher in subjects with mucosal invasive pathogens (rotavirus and enteropathogenic Escherichia coli) compared with children excreting Vibrio cholera and enterotoxigenic E. coli. Two-week zinc supplementation significantly reduced lactulose excretion in both AD and PD, whereas the change in mannitol excretion and L/M was similar between study groups in both studies. Changes in lactulose excretion were significantly influenced by zinc supplementation in children with E. coli, Shigella sp., and Campylobacter jejuni stool isolates. The greatest reduction in total lactulose excretion was seen in supplemented children who on presentation were lighter (wt/age less than 80%), thinner (wt/ht less than 85%), and undernourished [middle upper arm circumference (MUAC) less than 12.5 cm] or with hypozincaemia (less than 14 mumol/L).(ABSTRACT TRUNCATED AT 250 WORDS)
锌已被证明可促进肠病性肢端皮炎患者的肠道黏膜修复;但锌对急性腹泻(AD)或持续性腹泻(PD)期间黏膜完整性的影响尚不清楚。111名3至24个月大的AD患儿和190名PD患儿被随机且对研究人员设盲,分别接受5毫克/千克体重/天的元素锌补充剂或复合维生素糖浆中的安慰剂,为期2周,同时连续监测肠道通透性、生化指标和人体测量指标。通透性测试通过口服20毫升溶液中的5克乳果糖/1克甘露醇进行,随后收集5小时尿液。尿中探针糖的比率与临床、生化和微生物学参数相关。就诊时,与年龄匹配的无症状儿童相比,AD和PD患儿的乳果糖排泄量均增加,甘露醇排泄量减少。与排泄霍乱弧菌和产肠毒素大肠杆菌的儿童相比,黏膜侵袭性病原体(轮状病毒和致病性大肠杆菌)感染的受试者的乳果糖/甘露醇比率(L/M)更高。为期两周的锌补充剂显著降低了AD和PD患儿的乳果糖排泄量,而两项研究中各研究组的甘露醇排泄量和L/M变化相似。大肠杆菌、志贺氏菌属和空肠弯曲菌粪便分离株感染的患儿,其乳果糖排泄量的变化受锌补充剂的显著影响。补充锌的患儿中,就诊时体重较轻(体重/年龄低于80%)、较瘦(体重/身高低于85%)、营养不良[上臂中部周长(MUAC)低于12.5厘米]或低锌血症(低于14微摩尔/升)的患儿,其总乳果糖排泄量下降幅度最大。(摘要截选至250词)